December 10, 2014
Learn about Immunotherapy and BRI's Work in Seattle Business Magazine
Read the latest on immunotherapy in Seattle Business Magazine:
"Immunotherapy research is rebooting Seattle’s biotech sector. It might even save your life." The potential for immunotherapy to provide a cure extends far beyond cancer. At BRI, scientists are using immunotherapy to target Type 1 diabetes, multiple sclerosis and rheumatoid arthritis. BRI's executive director Homer Lane is quoted.